MedPath

Interscalene Block and Dysfunction Diaphragmatic

Phase 3
Completed
Conditions
Diaphragmatic Paralysis
Interventions
Registration Number
NCT04173364
Lead Sponsor
University Hospital, Lille
Brief Summary

The study seeks to show that interscalene injection of a small volume (\<8ml) of ropivacaine at a low concentration (0.1%) reduces the frequency of hemi-diaphragmatic paresis compared to low volume injection at the standard concentration (0.5%) in patients undergoing arthroscopic shoulder surgery with ISB.

Detailed Description

It's a prospective monocentric randomized controlled clinical trial in 2 parallel groups in double blind.

the study concerns patients undergoing arthroscopic shoulder surgery with ISB. The study seeks to show that interscalene injection of a small volume (\<8ml) of ropivacaine at a low concentration (0.1%) reduces the frequency of hemi-diaphragmatic paresis compared to low volume injection at the standard concentration (0.5%) in patients undergoing arthroscopic shoulder surgery with ISB.

Randomization in one of the two arms:

* Experimental group: \<8ml ropivacaine 0.1%.

* Control group: \<8mL of ropivacaine 0.5%.

Evaluation of diaphragmatic stroke by ultrasound and ventilatory function by spirometry and snip test before performing the ISB, then after installation of the ISB.

Performing the surgical procedure under general anesthesia assessment of postoperative analgesia and patient satisfaction during the following 48 hours.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • orthopedic surgery compatible with interscalene block
  • french speaking
  • Patient who signed consent to participate in the study
Exclusion Criteria
  • Pregnant woman
  • ASA score > 3
  • Severe chronic respiratory insufficiency
  • COPD >3 or 4 of Gold score
  • coagulation trouble
  • Allergic to medication involved in the study
  • Breastfeeding women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental group : ropivacaine 0.1%Ropivacaine 0.1% Injectable SolutionInterscalene block for arthroscopic shoulder surgery with small volume of low concentration (0.1%) of ropivacaine
control group : ropivacaine 0.5%Ropivacaine 0.5% Injectable SolutionInterscalene block for arthroscopic shoulder surgery with small volume of standard concentration (0.5%) of ropivacaine
Primary Outcome Measures
NameTimeMethod
Compare the occurrence of hemi-diaphragmatic paresis1h after interscalene block

Hemi diaphragmatic paresis is evaluated by quantifying the homolateral diaphragmatic stroke at interscalene block (ISB) by ultrasound analysis (measured in centimeter), during slow and deep inspiration. Diaphragmatic hemiparesis is defined as a decrease (at post-ISB time vs. pre-ISB time) of more than 25% of the diaphragmatic stroke during this slow and deep inspiration.

Secondary Outcome Measures
NameTimeMethod
Compare the frequency of hemi-diaphragmatic paralysis1h after interscalene block

Hemi-diaphragmatic paralysis refers to the absence of diaphragmatic movement (or paradoxical movement) in ultrasound during rest ventilation and slow, deep inhalation.

Compare postoperative analgesia24 hours postoperatively

Duration of effective analgesia (defined as the period up to the first EVA \> 3 (excluding PACU Consumption of morphine in PACU and analgesics within the first 24 hours.

Compare patient satisfaction24 to 48 hours postoperatively

Evaluation of patient satisfaction by questionnaire at the patient's bedside or by telephone call within 24h-48h postoperatively. It is assessed on a numerical scale from 0 to 10 (0 being the lowest satisfaction value and 10 the highest value)

Compare the ventilatory function (spirometry and snip test).1h after interscalene block

Presence of a respiratory impairment detected by spirometry (Spiro-USB® device) and presence of a diaphragmatic impairment detected by snip test, (micro-RPM®). Ventilation impairment will be considered present if there is a decrease of at least 25% in vital capacity between the pre and post ISB. Diaphragmatic damage is defined as a decrease of at least 25% in the Snip-test values between the pre and post ISB.

Compare intraoperative analgesiaperoperative time

Total consumption of sufentanil, and Analgesia Nociception Index values (ANI, MetroDoloris, France).

Compare the contralateral diaphragmatic stroke1h after interscalene block

Evaluation of contralateral diaphragmatic compensation (diaphragmatic stroke in ultrasound, comparison of post-ISB time vs. pre-ISB time, expressed in %).

Trial Locations

Locations (1)

Hôpital Roger Salengro, CHU

🇫🇷

Lille, France

© Copyright 2025. All Rights Reserved by MedPath